Metabolic profiles of cancer cells
By Julian L. Griffin, J. Shockcor. Nature Reviews. Cancer, 2004
720 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Spectroscopy
View Paper: https://www.semanticscholar.org/paper/d976ca89429b43a827368a7af7de21f1d7ff79d1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Molecular Biology
- David I. Ellis
- Royston Goodacre
- Yun Xu
- Howbeer Muhamadali
- Elon Santos Correa
- Michael L. Turner
- P. Gromski
- S. Venneti
In Spectroscopy
- Royston Goodacre
- Yun Xu
- Myrna J. Simpson
- David I. Ellis
- J. Spratlin
- Edward G. Nagato
- S. Eckhardt
- Brian P. Lankadurai
Citations in the corpus
- Glutaminolysis: A Hallmark of Cancer Metabolism. (2017, background): “1H-MRSI is a well-established metabolic clinical tool that takes advantage of the increased detection sensitivity and high abundance of 1H within human cancers (150).”
- Environmental metabolomics: an emerging approach to study organism responses to environmental stressors (2013, background): “For example, metabolic profiles of cancer cells have been used to monitor and understand tumor progression (Griffiths et al. 2002; Griffiths and Stubbs 2003; Griffin and Shockcor 2004).”
- Clinical Applications of Metabolomics in Oncology: A Review (2009, methodology): “org Clin Cancer Res 2009;15(2) January15, 2009 432”
- A tutorial review: Metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding. (2015, background): “The high precision of mass spectrometry (MS) and the reproducibility of nuclear magnetic resonance (NMR) spectroscopy combined with their ability to elucidate chemical structures [50–52] have resulted in these being the most common analytical technologies employed for metabolomics studies.”